Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vyvanse versus Concerta with placebo reference in adolescents with ADHD
2011-005452-34Phase 4Completed
- Sponsor
- Takeda
- Start
- Apr 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lisdexamfetamine, methylphenidate in attention deficit hyperactivity disorder (ADHD), sponsored by Takeda. Started Apr 2013; status: completed.
02
Drugs
lisdexamfetaminemethylphenidate
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on 2011-005452-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-005452-34.